Depression up in post-radiation head and neck cancer survivors

August 16, 2013
Depression up in post-radiation head & neck cancer survivors
For post-radiotherapy survivors of head and neck cancer, depression is fairly common, but treatment is underutilized, according to research published online Aug. 15 in JAMA Otolaryngology-Head & Neck Surgery.

(HealthDay)—For post-radiotherapy survivors of head and neck cancer, depression is fairly common, but treatment is underutilized, according to research published online Aug. 15 in JAMA Otolaryngology-Head & Neck Surgery.

Allen M. Chen, M.D., from the University of California in Davis, and colleagues conducted a cross-sectional analysis involving 211 patients with squamous cell carcinoma of the head and neck, who had been previously treated with radiotherapy, to determine the prevalence of self-reported . Rates of depression were analyzed using the self-administered University of Washington Quality of Life Instrument.

The researchers observed no difference in the mean mood score at one, three, and five years after treatment. At one, three, and five years, respectively, 17, 15, and 13 percent of patients reported their mood as somewhat or extremely depressed. The presence of tracheostomy tube or laryngeal stoma, gastrostomy tube dependence, and continued smoking at follow-up correlated significantly with post-radiotherapy depression. At one, three, and five years of follow-up, the proportion of those who were somewhat or extremely depressed and were using antidepressants was 6, 11, and 0 percent, respectively, while 3, 6, and 0 percent, respectively, were actively undergoing psychotherapy and/or counseling.

"Despite a relatively high rate of depression among with in the post-radiotherapy setting, mental health services are severely underutilized," the authors write.

Explore further: Tonsillectomy pre-radiation ups survival in early tonsil CA

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Tonsillectomy pre-radiation ups survival in early tonsil CA

April 19, 2013
(HealthDay)—For patients with stage I and II primary tonsil carcinoma, radiotherapy after tonsillectomy is associated with improved overall survival (OS) and disease-specific survival (DSS), compared with radiotherapy after ...

Racial disparity in head and neck cancer outcomes

April 19, 2013
(HealthDay)—Among Medicaid beneficiaries diagnosed with head and neck cancer, considerable racial disparities exist in treatment patterns and survival, according to a study published online April 18 in JAMA Otolaryngology-Head ...

Newer radiation technology improves head and neck cancer patients' long-term quality of life

January 26, 2012
Patients treated with IMRT for head and neck cancer report an increasingly better quality of life post-treatment when compared to patients receiving other forms of radiation therapy, according to a study presented at the ...

Most cancer survivors have good psychological outcomes

June 30, 2013
(HealthDay)—Certain factors predict anxiety, depression, and comorbid anxiety-depression at one year in adult cancer survivors, according to research published online June 17 in the Journal of Clinical Oncology.

Carbon ion radiotherapy safe and effective for treating inoperable spinal tumors

August 12, 2013
A new analysis has found that a type of radiation therapy called carbon ion radiotherapy can control cancer growth and prolong survival in patients with spinal tumors. Published early online in Cancer, a peer-reviewed journal ...

Recommended for you

Bolstering fat cells offers potential new leukemia treatment

October 16, 2017
Killing cancer cells indirectly by powering up fat cells in the bone marrow could help acute myeloid leukemia patients, according to a new study from McMaster University.

Study reveals complex biology, gender differences, in kidney cancer

October 13, 2017
A new study is believed to be the first to describe the unique role of androgens in kidney cancer, and it suggests that a new approach to treatment, targeting the androgen receptor (AR), is worth further investigation.

Cholesterol byproduct hijacks immune cells, lets breast cancer spread

October 12, 2017
High cholesterol levels have been associated with breast cancer spreading to other sites in the body, but doctors and researchers don't know the cause for the link. A new study by University of Illinois researchers found ...

New drug hope for rare bone cancer patients

October 12, 2017
Patients with a rare bone cancer of the skull and spine - chordoma - could be helped by existing drugs, suggest scientists from the Wellcome Trust Sanger Institute, University College London Cancer Institute and the Royal ...

Scientists pinpoint surprising origin of melanoma

October 12, 2017
Led by Jean-Christophe Marine (VIB-KU Leuven), a team of researchers has tracked down the cellular origin of cutaneous melanoma, the deadliest form of skin cancer. The team was surprised to observe that these very aggressive ...

Team finds a potentially better way to treat liver cancer

October 12, 2017
A Keck School of Medicine of USC research team has identified how cancer stem cells survive. This finding may one day lead to new therapies for liver cancer, one of the few cancers in the United States with an incidence rate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.